Loading...
OTCM
LNDZF
Market cap361kUSD
Jul 15, Last price  
0.01USD
1D
0.00%
IPO
-99.09%
Name

Salona Global Medical Device Corp

Chart & Performance

D1W1MN
No data to show
P/E
P/S
0.01
EPS
Div Yield, %
Shrs. gr., 5y
16.81%
Rev. gr., 5y
81.88%
Revenues
63m
+58.13%
359,0122,102,6173,944,4083,939,0693,146,866352,130-33,54718,312,26939,605,17962,627,451
Net income
-16m
L-18.21%
-922,249-3,091,383-8,661,597-8,059,642-760,569-2,380,958-2,667,423-4,372,019-19,075,686-15,602,915
CFO
-919k
L-7.47%
803,822-20,698,7793,544,1413,075,5274,000,989-128,047-975,174-3,703,879-993,077-918,908
Dividend
May 24, 20170.0055 USD/sh
Earnings
Aug 11, 2025

Profile

Salona Global Medical Device Corporation, through its subsidiaries, engages in the production and sale of medical devices and products in the United States. The company's medical devices are used for pain management, cold and hot therapy, transcutaneous electronic nerve and neuromuscular electrical stimulation, pulsed electromagnetic field technology, and ultrasound therapy. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Brattle Street Investment Corp. and changed its name to Salona Global Medical Device Corporation in December 2020. Salona Global Medical Device Corporation was incorporated in 2013 and is headquartered in Del Mar, California.
IPO date
Mar 28, 2014
Employees
144
Domiciled in
US
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122022‑022021‑022020‑022019‑022018‑022017‑022016‑02
Income
Revenues
62,627
242.00%
39,605
-118,158.78%
Cost of revenue
64,250
Unusual Expense (Income)
NOPBT
(1,623)
39,605
NOPBT Margin
100.00%
Operating Taxes
57
3,761
Tax Rate
9.50%
NOPAT
(1,680)
35,844
Net income
(15,603)
256.88%
(19,076)
615.14%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
18,007
Long-term debt
14,593
575
Deferred revenue
Other long-term liabilities
34,772
Net debt
31,681
(1,354)
Cash flow
Cash from operating activities
(919)
(993)
CAPEX
(203)
(767)
Cash from investing activities
(1,519)
(6,717)
Cash from financing activities
825
466
FCF
(9,860)
24,663
Balance
Cash
919
1,928
Long term investments
Excess cash
Stockholders' equity
(9,142)
7,259
Invested Capital
37,836
52,050
ROIC
128.76%
ROCE
76.09%
EV
Common stock shares outstanding
73,472
54,841
Price
Market cap
EV
EBITDA
862
41,775
EV/EBITDA
Interest
2,640
Interest/NOPBT